The Claim
Soluble uric acid at physiological concentrations (200–400 µM) inhibits CD38, leading to preserved cellular NAD+ levels, activation of SIRT1, suppression of NF-κB and NLRP3 inflammasome activation, reduced inflammation, and enhanced autophagy, indicating a protective role in metabolic and age-related inflammation.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
At normal levels in the body, uric acid reduces inflammation and increases autophagy by blocking CD38, which maintains NAD+ and activates SIRT1, leading to decreased activation of NF-κB and NLRP3 inflammasomes.
See the scientific wording
Soluble uric acid at physiological concentrations (200–400 µM) inhibits CD38, thereby preserving cellular NAD+ levels and activating SIRT1, which suppresses NF-κB and NLRP3 inflammasome activation, reducing inflammation and promoting autophagy; this suggests a protective role for uric acid in metabolic and age-related inflammation.
At normal levels, uric acid blocks a protein that breaks down a vital energy molecule inside cells. This lets the energy molecule build up and turn on a cleanup system that shuts down inflammation and removes damaged cell parts. Without this block, inflammation spreads and cells start to die, causing tissue damage.
What the research says
1 studyAt normal levels, uric acid acts like a helper that blocks a protein called CD38, which lets cells keep more energy (NAD+) and turn off inflammation, helping clean up damaged parts. The study confirms this exact mechanism happens at normal uric acid levels.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.